BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38194681)

  • 1. Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
    O'Connor D; Valle-Inclán JE; Conde L; Bloye G; Rahman S; Costa JR; Bartram J; Adams S; Wright G; Elrick H; Wall K; Dyer S; Howell C; Jigoulina G; Herrero J; Cortes-Ciriano I; Moorman AV; Mansour MR
    Blood; 2024 Mar; 143(10):933-937. PubMed ID: 38194681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
    Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
    Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of relapse of adult T cell acute lymphoblastic leukemia.
    Sentís I; Gonzalez S; Genescà E; García-Hernández V; Muiños F; Gonzalez C; López-Arribillaga E; Gonzalez J; Fernandez-Ibarrondo L; Mularoni L; Espinosa L; Bellosillo B; Ribera JM; Bigas A; Gonzalez-Perez A; Lopez-Bigas N
    Genome Biol; 2020 Nov; 21(1):284. PubMed ID: 33225950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes.
    Ford AM; Fasching K; Panzer-Grümayer ER; Koenig M; Haas OA; Greaves MF
    Blood; 2001 Aug; 98(3):558-64. PubMed ID: 11468150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
    Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
    Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
    Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.
    Szczepanski T; van der Velden VH; Waanders E; Kuiper RP; Van Vlierberghe P; Gruhn B; Eckert C; Panzer-Grümayer R; Basso G; Cavé H; Stadt UZ; Campana D; Schrauder A; Sutton R; van Wering E; Meijerink JP; van Dongen JJ
    J Clin Oncol; 2011 Apr; 29(12):1643-9. PubMed ID: 21357790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis.
    Bellido M; Martino R; Aventín A; Carnicer MJ; Rubiol E; López O; Sierra J; Nomdedéu JF
    Haematologica; 2000 Oct; 85(10):1083-6. PubMed ID: 11025601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.
    Heesch S; Goekbuget N; Stroux A; Tanchez JO; Schlee C; Burmeister T; Schwartz S; Blau O; Keilholz U; Busse A; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
    Haematologica; 2010 Jun; 95(6):942-9. PubMed ID: 20435628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase.
    Hsiao MH; Yu AL; Yeargin J; Ku D; Haas M
    Blood; 1994 May; 83(10):2922-30. PubMed ID: 8180387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation.
    Chen S; Huang X; Zheng H; Geng S; Wu X; Yang L; Weng J; Du X; Li Y
    Mol Cancer; 2013 Jul; 12():73. PubMed ID: 23849082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blasts.
    Bessho F; Takayama N; Fronkova E; Zuna J
    Int J Hematol; 2013 Apr; 97(4):525-8. PubMed ID: 23420181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 mutations in T-ALL.
    Tosello V; Mansour MR; Barnes K; Paganin M; Sulis ML; Jenkinson S; Allen CG; Gale RE; Linch DC; Palomero T; Real P; Murty V; Yao X; Richards SM; Goldstone A; Rowe J; Basso G; Wiernik PH; Paietta E; Pieters R; Horstmann M; Meijerink JP; Ferrando AA
    Blood; 2009 Jul; 114(5):1038-45. PubMed ID: 19494353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
    Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
    Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of a Very Late Isolated Relapse in an Adolescent With a PICALM-MLLT10 Positive T-lineage Acute Lymphoblastic Leukemia.
    Cannata E; Samperi P; Cimino C; Marino S; Sullo F; Mirabile E; Di Cataldo A; Russo G; Lo Nigro L
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e191-e194. PubMed ID: 29189509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
    Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
    Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.
    Balbach ST; Makarova O; Bonn BR; Zimmermann M; Rohde M; Oschlies I; Klapper W; Rössig C; Burkhardt B
    Leukemia; 2016 Apr; 30(4):970-3. PubMed ID: 26216196
    [No Abstract]   [Full Text] [Related]  

  • 20. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.